Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2018 (9) TMI AT This

  • Login
  • Cases Cited
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2018 (9) TMI 1131 - AT - Central Excise


Issues: Classification of goods under Central Excise Tariff Act, 1985

Analysis:
1. Issue: Classification of goods under Tariff Item No.3004.50.90 or Chapter 15 of Schedule to Central Excise Tariff Act, 1985.
- Details: The dispute arose regarding the classification of goods called SIOOXY. The revenue contended that the goods fell under Tariff Item No.3004.50.90 as medicaments, while the appellant argued they should be classified under Chapter 15 as dietary supplements. Various show cause notices led to the impugned Order-in-Appeal classifying the goods under Chapter 30.
- Judgment: The Tribunal noted that Heading No.30.04 covers medicaments for therapeutic uses, whereas the appellant claimed the goods were sold as dietary supplements, not medicines. The appellant cited the HSN Explanatory notes and a previous Tribunal order to support their classification argument.

2. Issue: Interpretation of classification under Central Excise Tariff Act.
- Details: The appellant argued that the goods should be classified under CTH 1515 90, not under CTH 3004 as medicaments. They highlighted that the product description indicated no medicinal use and contained natural ingredients with antioxidant properties.
- Judgment: The Tribunal found that the product did not have therapeutic or prophylactic properties as claimed by the revenue. They referred to previous cases to support the classification under CTH 1515 90, emphasizing that natural properties alone do not classify a product as a medicament.

3. Issue: Verification of product properties by Drug Control Authorities.
- Details: The Tribunal raised concerns about whether the revenue had the product tested by Drug Control Authorities to confirm therapeutic properties and if natural ingredients were encapsulated without chemical modification.
- Judgment: The Tribunal remanded all four appeals to the Original authority for verification of these facts and to decide the matter afresh in line with the Final order of the Tribunal in a similar case. They emphasized providing the appellant with a fair hearing during the process.

In conclusion, the Tribunal allowed all the appeals by way of remand, directing the Original authority to verify specific facts regarding the product properties and classify the goods accordingly, ensuring a fair hearing for the appellant.

 

 

 

 

Quick Updates:Latest Updates